A detailed history of Golden State Wealth Management, LLC transactions in Cel Sci Corp stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 100 shares of CVM stock, worth $38. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$38
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

BUY
$0.4 - $1.11 $40 - $111
100 New
100 $40,000
Q2 2020

Aug 11, 2020

SELL
$9.75 - $17.6 $975 - $1,760
-100 Closed
0 $0
Q1 2020

Apr 17, 2020

BUY
$7.54 - $17.05 $754 - $1,705
100 New
100 $1,000

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $16.5M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Golden State Wealth Management, LLC Portfolio

Follow Golden State Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Wealth Management, LLC with notifications on news.